DECR2 and posterior cortical atrophy: Herein, we showed that combination of DECR2 inhibition or TDZ with enzalutamide further abrogated PCa cell proliferation of 22Rv1, V16D and MR49F PCa cells and overexpression of DECR2 confers LNCaP cells to be more resistant to enzalutamide.